Neuroendovascular coiling is a procedure performed to block blood flow into an aneurysm (a weakened area in the wall of an artery). Endovascular coiling is a more recent treatment for brain aneurysms; it has been used in patients since 1991. A neuroendovascular coil is used to treat an unruptured and ruptured brain aneurysm (a weakened area in the artery wall). A number of factors can contribute for developing an aneurysm and weakness in an artery wall such as old age, smoking, high blood pressure, drug abuse, head injuries, heavy alcohol consumption, certain blood infection, low estrogen level, and others. Diagnosis of the ruptured aneurysms can be done by the computed tomography (CT) scan after the signs of the subarachnoid hemorrhage. If computed tomography scan shows negative signs, then a lumbar puncture can be performed to detect blood in the cerebrospinal fluid to confirm an aneurysm. The computed tomography angiography (CTA) is also widely performed to detect and analyze the aneurysm.
Market Dynamics
High incidence of brain aneurysms is one major factor driving the market growth. According to a data published by the Brain Aneurysm Foundation in 2020, an estimated 6.5 million people in the U.S. are suffering from unruptured brain aneurysm, which accounts for around 1 in 50 people. Additionally, an estimated 500,000 deaths are caused due to brain aneurysms across the globe each year.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook